Source: Aastrom Biosciences, Inc.
Date: June 27, 2007
Summary:
In an official news release, Aastrom Biosciences, Inc., a regenerative medicine company, announced that the first critical limb ischemia (CLI) patient was treated at the Malcom Randall Veterans Affairs (VA) Medical Center in Gainesville, FL. The Company is evaluating its Vascular Repair Cell (VRC) product in a U.S. Phase IIb clinical trial to treat patients suffering from CLI, the most severe form of peripheral arterial disease (PAD).
